This bill aims to establish coverage for the diagnosis and treatment of Alzheimer's disease and other dementia-related diseases under the State and Public School Life and Health Insurance Program. It introduces a new section, 21-5-425, which outlines the legislative findings regarding the prevalence and impact of Alzheimer's disease in Arkansas, emphasizing the importance of timely diagnosis and treatment. The bill states that health benefit plans for state and public school employees, effective January 1, 2026, must provide coverage for these services as determined by a licensed physician.

The coverage mandated by this bill includes FDA-approved treatments and medications aimed at slowing the progression of Alzheimer's disease, as well as necessary diagnostic testing. Additionally, the bill specifies that the coverage will not be subject to step therapy protocols, ensuring that patients receive appropriate care without unnecessary delays. The State Board of Finance is authorized to create rules for the implementation of this new coverage requirement.